Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

November 18, 2022

FDA Accepts and Closes Impella® Post-Approval Studies for Major Indications

Chuck Simonton, MD, reviews that in October 2022 the FDA accepted and closed all Impella post-approval studies for high-risk PCI, cardiogenic shock, post-cardiotomy cardiogenic shock and right heart failure.

October 5, 2022

REVIVED-BCIS2 Interview: Gregg Stone and Divaka Perera

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain.

October 5, 2022

STEMI DTU™: “Unloading Is Not Delaying Treatment” 

Vijay Iyer, MD, discusses important concepts being explored in the STEMI-DTU™ trial, emphasizing that unloading is not delaying treatment. 

October 1, 2022

TCT 2022: Limitations & Opportunities of Observational Database Analyses

Jay Giri, MD, discusses the pros, cons, and best uses for five types of observational database analyses.

September 30, 2022

TCT 2022: Lessons Learned in STEMI DTU™ Pilot Study

Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation from TCT 2022. 

September 29, 2022

Live from TCT – September 17, 2022

Seth Bilazarian, MD, and Chuck Simonton, MD, recap highlights from day one of TCT 2022 and interview Greg Stone, MD and Alaide Chieffo, MD, FESC.

September 28, 2022

Live from TCT – September 18, 2022

This recap of highlights from day two of TCT 2022 includes interviews with Drs. Sanjit Jolly, Navin Kapur, Adrian Attinger-Toller and Taishi Hirai.

September 28, 2022

Live from TCT – September 19, 2022

Day three highlights from TCT 2022 include several late-breaking trials and interviews with Navin Kapur, MD, and Koichi Toda, MD, PhD.

September 27, 2022

TCT 2022: OPTIMUM Study Sub-Analysis Results

Adam Salisbury, MD, presents preliminary results from the OPTIMUM Study at TCT 2022.

September 27, 2022

TCT 2022: Influential Trials in High-Risk PCI

At TCT 2022, Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.

September 16, 2022

TCT 2022: Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.

September 16, 2022

TCT 2022: Data Integrity in Real-World Evidence

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

August 26, 2022

Case Study Epitomizing Results from RESTORE EF  

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

August 15, 2022

RESTORE EF: Ejection Fraction Improvement with Complete Revascularization

Mitul Patel, MD, discusses the RESTORE EF study and a successful case of improved ejection fraction with complete revascularization.

August 15, 2022

RESTORE EF Case Study: Contemporary Practices for Impella®-Supported Complete Revascularization

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

NPS-1674